Evidence map›Paper›PMID 34091591›Full record

ReviewTranslational psychiatry2021

Genetic variations influence brain changes in patients with attention-deficit hyperactivity disorder.

Santosh K Yadav, Ajaz A Bhat, Sheema Hashem, Sabah Nisar, Madeeha Kamal, Najeeb Syed, Mohamed-Ramzi Temanni, Rakesh K Gupta, Saddat Kamran, Muhammad Waqar Azeem and 7 more

Open access · goldAbstract readReview
In one paragraph

Review in Translational psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
8.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Central Med23 deficiency leads to malformation of dentate gyrus and ADHD-like behaviors in mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  16. Article
  17. Connectome-based symptom mapping andmedRxiv : the preprint server for health sciences · 2024
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 3 countries.

Santosh K YadavLaboratory of Molecular and Metabolic Imaging, Sidra Medicine, Doha, Qatar.
Ajaz A BhatLaboratory of Molecular and Metabolic Imaging, Sidra Medicine, Doha, Qatar.ORCID 0000-0003-3640-6275
Sheema HashemLaboratory of Molecular and Metabolic Imaging, Sidra Medicine, Doha, Qatar.
Sabah NisarLaboratory of Molecular and Metabolic Imaging, Sidra Medicine, Doha, Qatar.
Madeeha KamalDepartment of Pediatrics, Sidra Medicine, Doha, Qatar.
Najeeb SyedApplied Bioinformatics Core, Research Branch, Sidra Medicine, Doha, Qatar.
Mohamed-Ramzi TemanniApplied Bioinformatics Core, Research Branch, Sidra Medicine, Doha, Qatar.
Rakesh K GuptaDepartment of Radiology and Imaging, Fortis Memorial Research Institute, Gurgaon, Haryana, India.
Saddat KamranNeuroscience Institute, Hamad General Hospital, Doha, Qatar.ORCID 0000-0002-0260-2086
Muhammad Waqar AzeemDepartment of Psychiatry, Sidra Medicine, Doha, Qatar.
Amit K SrivastavaDepartment of Pediatric Surgery, McGovern Medical School, University of Texas Health Sciences Center at Houston, Houston, TX, 77030, USA.
Puneet BaggaDepartment of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, TN, USA.
Sanjeev ChawlaDepartment of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104, USA.
Ravinder ReddyCenter for Magnetic Resonance and Optical Imaging, Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104, USA.
Michael P FrenneauxAcademic Health System, Hamad Medical Corporation, Doha, Qatar.
Khalid FakhroDepartment of Human Genetics, Sidra Medicine, Doha, Qatar.ORCID 0000-0002-3150-1276
Mohammad HarisLaboratory of Molecular and Metabolic Imaging, Sidra Medicine, Doha, Qatar. mharis@sidra.org.ORCID 0000-0002-4945-2935
University of Pennsylvania · USFortis Memorial Research Institute · INHamad General Hospital · QAHamad Medical Corporation · QAQatar Airways (Qatar) · QASt. Jude Children's Research Hospital · USThe University of Texas Health Science Center at Houston · USWeill Cornell Medical College in Qatar · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Attention-deficit hyperactivity disorder (ADHD) is a neurological and neurodevelopmental childhood-onset disorder characterized by a persistent pattern of inattentiveness, impulsiveness, restlessness, and hyperactivity. These symptoms may continue in 55-66% of cases from childhood into adulthood. Even though the precise etiology of ADHD is not fully understood, it is considered as a multifactorial and heterogeneous disorder with several contributing factors such as heritability, auxiliary to neurodevelopmental issues, severe brain injuries, neuroinflammation, consanguineous marriages, premature birth, and exposure to environmental toxins. Neuroimaging and neurodevelopmental assessments may help to explore the possible role of genetic variations on ADHD neuropsychobiology. Multiple genetic studies have observed a strong genetic association with various aspects of neuropsychobiological functions, including neural abnormalities and delayed neurodevelopment in ADHD. The advancement in neuroimaging and molecular genomics offers the opportunity to analyze the impact of genetic variations alongside its dysregulated pathways on structural and functional derived brain imaging phenotypes in various neurological and psychiatric disorders, including ADHD. Recently, neuroimaging genomic studies observed a significant association of brain imaging phenotypes with genetic susceptibility in ADHD. Integrating the neuroimaging-derived phenotypes with genomics deciphers various neurobiological pathways that can be leveraged for the development of novel clinical biomarkers, new treatment modalities as well as therapeutic interventions for ADHD patients. In this review, we discuss the neurobiology of ADHD with particular emphasis on structural and functional changes in the ADHD brain and their interactions with complex genomic variations utilizing imaging genetics methodologies. We also highlight the genetic variants supposedly allied with the development of ADHD and how these, in turn, may affect the brain circuit function and related behaviors. In addition to reviewing imaging genetic studies, we also examine the need for complementary approaches at various levels of biological complexity and emphasize the importance of combining and integrating results to explore biological pathways involved in ADHD disorder. These approaches include animal models, computational biology, bioinformatics analyses, and multimodal imaging genetics studies.

Indexed as

Attention Deficit Disorder with HyperactivityAdultAnimalsBrainChildGenetic Predisposition to DiseaseGenetic VariationHumansNeuroimaging

Identifiers

PMID34091591
PMCPMC8179928
OpenAlexW3170081252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.